Log In
BCIQ
Print this Print this
 

HMG-CoA reductase

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting HMG-CoA reductase

BCIQ
Print ChartPrint this
0 0 0 0 0 1 1 1 0 0 0 0 0 0 1 1 0 14 0 0 0 5 1 10 0 0 2 0 0 0
Phases of DevelopmentPreclinicalPilotPhase IIPhase IIIPhase IVMarketed
Autoimmune

0

0

2

0

0

0

Cardiovascular

0

0

0

5

1

10

Endocrine / Metabolic

0

0

1

1

0

14

Infectious

1

1

0

0

0

0

Neurology

0

0

0

0

0

1




 Products Targeting HMG-CoA reductase
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

9

$41,100.0M

$18,300.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today